PEPR Home  
        
spacer image Horizontal grey line spacer image
spacer image
spacer image
spacer image
spacer image
Background
spacer image
Design Goals
spacer image
Data Repository
 
Search Repository
spacer image
PEPR Tutorial
  spacer image    
spacer image spacer image spacer image
New User Registration
spacer image
spacer image
spacer image
spacer image Username: spacer image
spacer image spacer image
spacer image
spacer image Password: spacer image
spacer image spacer image
spacer image
spacer image Forgot Password? spacer image
spacer image
spacer image
spacer image
spacer image spacer image spacer image
Home
spacer image
spacer image
spacer image
spacer image
spacer image
spacer image

Spastic mouse

spacer image
Title Spastic mouse
Summary We build a model for the molecular and cellular events underlying phenotypic discordance in glycine receptor defects (beta subunit). Some mice progress and die, while their littermates recover and get better, despite the same mutation on an inbred genetic background. We find evidence for glycine neurotransmitter toxicity and loss of glycinergic interneurons early in the disease, but some mice are able to keep things going until they can over-express homomeric alpha1 channels, whereupon they recover. In the mice progressing towards lethality, neurotransmitter toxicity too quickly extends to GABAergic interneurons and motorneurons, and they lose their window of time to upregulate the alpha1 glycine receptor, and they crash and burn. Importantly, human patients with glycine receptor defects typically show a resolution of their phenotype with age, and we propose that the same remodeling events are occuring in human patients.
Hypothesis Our data suggests that functional recovery of GlyRb mutant mice is likely due to expression of homomeric glycine receptors, rescue from excitotoxicity, and subsequent neuronal remodeling. We propose that human patients with hyperekplexia (mutations of glycine receptors) show remodeling similar to that of the recovering spastic mice, as human patients also show a lessening of symptoms as a function of age.
Specific Aim Murine models for human Startle Disease show clinical variability between littermates. Here, we determined the molecular remodeling of spastic GlyRb mutant spinal cord through the course of the disease, and develop a model for clinical disparity between littermates. At young ages, all animals were spastic, showed loss of glycine receptors, increased expression of vesicular glycine/GABA transporter and NMDA receptors, induction of activated caspase3, and preferential loss of glycinergic interneurons consistent with neurotransmitter toxicity model. Those littermates that recovered from symptoms showed strong over-expression of the GlyRa1 subunit, and increased myelination and synaptic plasticity. Littermates that showed a deteriorating clinical course failed to over-express GlyRa1, and also showed relative loss of gephyrin. These molecular changes were associated with preferential loss of GABAergic interneurons, and extensive motorneuron loss.
Investigator Eric Hoffman
Type N/A
Time Factor N/A
Number of experiments 16
Last update 10/02/2001
spacer image
spacer image
16 dataset experiments Register  or   Logon to download the data.
Experiment selection Data
check all
check all
uncheck all
uncheck all
toggle check
toggle check

download

Offline Download

analysis

B6C3Fe-SpinalC-1moM-1aAv2-s2 B6C3Fe-SpinalC-1moM-1bAv2-s2 MSS-Ctr12moF-1aAv2-s2
MSS-Ctr12moF-1bAv2-s2 MSS-Ctr12moM-1aAv2-s2 MSS-Ctr12moM-1bAv2-s2
MSS-Ctr9moF-1aAv2-s2 MSS-Ctr9moF-1bAv2-s2 MSS-Ctr9moM-1aAv2-s2
MSS-Ctr9moM-1bAv2-s2 MSS-Spa-M6moF-1aAv2-s2 MSS-Spa-M6moF-1bAv2-s2
MSS-Spa-sev-3moM-1aAv2-s2 MSS-Spa1-2moF-1aAv2-s2 MSS-Spa2-2moF-1aAv2-s2
MSS-Spa3+moM-1aAv2-s2
spacer image

Grey dotspacer image